• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

    7/14/25 9:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care
    Get the next $SBC alert in real time by email

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company's strategy to expand its global footprint and enhance its medical excellence.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/

    Dr. Cohen

    Dr. Cohen

    Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With over 30 years of clinical experience, he is widely known for his pioneering work in regenerative aesthetics, including the clinical application of fat-derived stem cells, skeletal facial aesthetic surgery, and the integration of artificial intelligence into medical innovation. Dr. Cohen is also the inventor of the internal craniofacial distraction device and LipoCube, both of which have become global standards in the field.

    Recognized by Newsweek as one of "America's Best Plastic Surgeons," Dr. Cohen has authored numerous scientific publications and textbooks and is a sought-after speaker at international conferences. He is also a Clinical Professor at the University of California, San Diego, and an active member of several global societies, including the American Society of Plastic Surgeons (ASPS).

    Following its Nasdaq listing in September 2024, SBC Medical has accelerated its global growth initiatives. With Dr. Cohen's participation, the company aims to elevate its medical quality, strengthen brand positioning in international markets, expand academic collaborations, and enhance its physician training programs—further solidifying its presence as a truly global medical group.

    Message from Yoshiyuki Aikawa, CEO of SBC Medical

    "It is a great honor to welcome Dr. Steven R. Cohen, a world-class clinician, to our team. His deep expertise and global perspective will play a transformative role in elevating our medical standards, physician education, and brand development. We look forward to his contributions as we enter a new phase of growth."

    Message from Dr. Steven R. Cohen

    "I am honored to join SBC Medical, a company that is not only expanding rapidly but also committed to innovation and patient-centered care. SBC Medical's investment in physician education and international collaboration resonates deeply with my own values. I look forward to contributing to the advancement of safer, scientifically grounded, and aesthetically refined regenerative aesthetics on a global scale."

    About Dr. Steven R. Cohen (Partial Profile)

    • Board-certified in Plastic Surgery and Craniofacial Surgery
    • Founder and Medical Director, Faces+ (San Diego, California)
    • Clinical Professor of Plastic Surgery, University of California, San Diego
    • Inventor of the internal craniofacial distraction device and LipoCube
    • Recognized as one of America's Best Plastic Surgeons by Newsweek
    • Global authority in facial reconstruction, stem cell therapy, and 3D surgical simulation
    • Frequent keynote speaker at international academic societies; author of multiple books and peer-reviewed articles

    For more information about Dr. Steven R. Cohen, please visit: https://www.facesplus.com/about/dr-steven-r-cohen/

    About SBC Medical

    SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.

    For more information, visit https://sbc-holdings.com/

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250714547888/en/

    SBC Medical Group Holdings Incorporated (Asia)

    Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com

    Daisuke Murakami / Public Relations E-mail: pr@sbc.or.jp

    ICR LLC (In the US)

    Bill Zima / Managing Partner Email: bill.zima@icrinc.com

    Get the next $SBC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBC

    DatePrice TargetRatingAnalyst
    3/6/2026$8.00Buy
    BTIG Research
    More analyst ratings

    $SBC
    SEC Filings

    View All

    SEC Form DEFA14A filed by SBC Medical Group Holdings Incorporated

    DEFA14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

    5/28/26 6:12:56 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SEC Form DEF 14A filed by SBC Medical Group Holdings Incorporated

    DEF 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

    5/28/26 6:09:13 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Leadership Update

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    5/20/26 4:15:44 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Aikawa Yoshiyuki sold $1,405,462 worth of shares (465,000 units at $3.02), decreasing direct ownership by 0.59% to 78,839,460 units (SEC Form 4)

    4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/29/26 9:38:46 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Chairman and CEO Aikawa Yoshiyuki sold $9,369,750 worth of shares (3,100,000 units at $3.02), decreasing direct ownership by 4% to 79,304,460 units (SEC Form 4)

    4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/23/26 8:00:00 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by SBC Medical Group Holdings Incorporated

    4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    3/10/26 9:54:07 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on SBC Medical Group with a new price target

    BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

    3/6/26 8:35:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SBC Medical will participate in several upcoming investor conferences in May and June 2026

    IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in May and June 2026. SBC Medical will deliver webcast presentations and conduct one-on-one meetings with institutional investors. Below is a summary of the Company's scheduled participation in upcoming investor conferences: ConferenceDateTime (ET)FormatLinkLytham Partners– Spring 2026 Investor ConferenceMay 28—1-on-1 MeetingsRegistrationNoble Capital Markets– June 2026 Emerging G

    5/26/26 11:46:01 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok

    IRVINE, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced that its consulting partner in Thailand, BLEZ ASIA Co., Ltd. ("BLEZ ASIA") held an inauguration reception on May 21, 2026, to celebrate the opening of a new aesthetic dermatology section at BLEZ CLINIC in the Asok district of Bangkok. The event marks a significant milestone in SBC Medical's efforts to bring high-quality aesthetic healthcare services to the Thai market, with the section's service launch scheduled for June 2026. Thailand'

    5/22/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Announces First Quarter 2026 Financial Results

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights Total revenues were $43 million, representing a 9% year-over-year decrease. Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points. Earnings per share, which is defined as net income attributabl

    5/14/26 6:30:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Leadership Updates

    Live Leadership Updates

    View All

    SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

    3/2/26 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company's strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center

    7/14/25 9:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

    IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of

    7/1/25 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Financials

    Live finance-specific insights

    View All

    SBC Medical Group Holdings Announces First Quarter 2026 Financial Results

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights Total revenues were $43 million, representing a 9% year-over-year decrease. Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points. Earnings per share, which is defined as net income attributabl

    5/14/26 6:30:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical to Announce 1Q 2026 Financial Results

    IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026. Management will host an earnings conference call on May 14, 2026, at 8:30 a.m. Eastern Time. A question‑and‑answer session with analysts and investors will follow the prepared remarks. Please register in advance for the conference using the link provided below.https://zoom.us/webinar/register/WN_6RZgrwsUREiRpAmBBGTik

    5/1/26 10:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    10/1/24 9:00:18 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/24/24 9:07:03 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/23/24 9:02:53 AM ET
    $SBC
    Medical/Nursing Services
    Health Care